The court issued notice to the Centre and Bharat Biotech to file their reply on a PIL against Covaxin's clinical trials for age group 2 to 18.
The Delhi High Court has refused to stay the Centre’s notification which has accorded permission to conduct the Phase II/III clinical trial of Covaxin in the age group 2 to 18 years to its manufacturer Bharat Biotech Ltd.
However, the court issued notice to the Centre and Bharat Biotech to file their reply on a PIL against Covaxin’s clinical trials for age group 2 to 18.
Source: ILNS
ENC Network is part of ENC Private Ltd. Its state-of-the-art studios and editorial offices are located in a 5-acre complex in Sector 68 of the capital’s media hub, NOIDA.
© Copyright 2022 IndiaLegallive.com
